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Abstract 
This study was aimed at preparing, characterising and evaluating in situ gel formulations 
based on a blend of two hydrophilic polymers  i.e. poloxamer 407 (P407) and poloxamer 188 
(P188) for a sustained ocular delivery of ketorolac tromethamine (KT). Drug-polymer 
interaction studies were performed using DSC and FT-IR. The gelation temperature (Tsol-gel), 
gelation time, rheological behaviour, mucoadhesive characteristics of these gels, transcorneal 
permeation and ocular irritation as well as toxicity was investigated. DSC and FT-IR studies 
revealed that there may be electrostatic  interactions between the drug and the polymers used. 
P188 modified the Tsol/gel of P407 bringing it close to eye temperature (35
o
C) compared with 
the formulation containing P407 alone. Moreover, gels that comprised P407 and P188 
exhibited a pseudoplastic behaviour at different concentrations. Furthermore, mucoadhesion 
study using mucin discs showed that in situ gel formulations have good mucoadhesive 
characteristics upon increasing the concentration of P407. When comparing formulations 
PP11 and PP12, the work of adhesion decreased significantly (P < 0.001) from 377.9 ± 7.79 
mN.mm to 272.3 ± 6.11 mN.mm. In vitro release and ex vivo permeation experiments 
indicated that the in situ gels were able to prolong and control KT release as only 48% of the 
KT released within 12 h. In addition, the HET-CAM and BCOP tests confirmed the non-
irritancy of KT loaded in situ gels, and HET-CAM test demonstrated the ability of ocular 
protection against strongly irritant substances. MTT assay on primary corneal epithelial cells 
revealed that in situ gel formulations loaded with KT showed reasonable and acceptable 
percent cell viability compared with control samples.    
Key words: In situ gel, poloxamer, mucoadhesion, ocular delivery, ketorolac, physico-
chemical characterisation, toxicity studies, in vitro release, ex vivo permeation, HET-CAM 
test, BCOP test. 
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1. Introduction 
Conventional ophthalmic dosage forms, such as solutions and suspensions have many 
drawbacks, including - rapid precorneal elimination of the drug mainly due to nasolacrimal 
drainage (Abdelkader et al., 2011; Abdelkader et al., 2010), the need for frequent application, 
and pulse release from solutions in particular (Almeida et al., 2014). On the other hand, 
ophthalmic  ointments, although provide a prolonged contact with the eye, they may trigger 
foreign body sensation, blurred vision and cause  inconvenience to the patient (Abdelkader & 
Alany, 2012; Sintzel et al., 1996). 
A relatively novel strategy in increasing the contact time of ocular formulations is through the 
formation of in situ gels using environment responsive polymers (Rupenthal et al., 2011; T.R. 
Thrimawithana et al., 2012). These polymer-based systems are liquid at room temperature, 
but undergo sol-gel transition on the ocular surface hence prolonging ocular residence time 
(Almeida, et al., 2014). Stimuli that may trigger sol-gel phase transition of the polymer 
network on the ocular surface could be owing to physical (temperature, light) or chemical 
(ions, pH). Amongst the natural polysaccharides that are considered as ion-activated polymers, 
the popular ones include gellan gum, kappa-carrageenan, alginates and xanthan gum. These 
polymers are able to interact with different cations that can be used to form ion-activated in situ 
gelling systems.(Fernández-Ferreiro  et al., 2015). 
 Gellan gum and xanthan gum are the constituents of the commercially available products 
Timoptic® XE (Merck) and Timoptic® GFS (Alcon) respectively. These exhibit phase 
transition with increased ionic strength (Abdelkader & Mansour, 2015). Also, it has been 
found that the extent of gel-formation of gellan gum increases proportionally with the amount 
of mono- or divalent cations present in the tear fluid. Hence, the main triggering effect 
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inducing phase transition is the adequate availability of mono- and divalent cations associated 
with reflex tearing (Rupenthal et al., 2011; Thrimawithanaa et al., 2011).  
On the other hand, carbopol is a polyacrylic acid (PAA) polymer, which exhibits sol-gel 
transition in an aqueous solution upon raising the pH above its pKa of 5.5. However, with the 
increase in the concentration of carbopol in the vehicle, in order to improve its rheological 
properties, the acidity of the vehicle increases. This increase in the acidity of the vehicle 
could induce ocular tissue irritation and induce lacrimation (Nanjawade et al., 2007) . 
Also among commonly used in situ gel polymers is poloxamer 407 (P407), a 
thermoresponsive polymer that exists in a liquid state at low temperature i.e. between 4–5oC 
at a concentration range of 20-30% w/w, while converting into a gel upon increasing the 
temperature of the medium. P407 is a non-ionic polymer (polyoxyethylene-
polyoxypropylene-polyoxyethylene; PEOn–PPOn–PEOn), consisting of a central 
hydrophobic block of polypropylene glycol in addition to hydrophilic blocks of 
polyoxyethylene (Baeyens et al., 1997). P407 has been widely used in nasal (Li  et al., 2014), 
ophthalmic (Hao et al., 2014), vaginal (Rossi et al., 2014), and topical (Heilmann et al., 2013)  
formulations. However, one of the limitations of P407 is its weak mechanical strength 
leading to a rapid erosion of the polymer. Furthermore, it was previously reported  that P407 
at a concentration of 18% (w/v)  or higher, has the ability to transform from a low viscosity 
solution into a gel under the ambient temperature (Kim et al., 2002; Qi et al., 2007). 
However, at this concentration the solution will lose its gelation ability after being diluted by 
lacrimal fluid upon instillation into the eye. Hence, 25% (w/w) P407 can be used in order to 
ensure the completion of the phase transition process of the polymer under ocular 
physiological condition. But, under these circumstances, the gelation temperature will be 
lower than room temperature and P407 solution have to be stored in the fridge, which makes 
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it inconvenient for use (Wei et al., 2002). Therefore, P188, which is an analog of P407, may 
be added to P407 solution as a gelation temperature modifying substance (Kim, et al., 2002; 
Qi, et al., 2007). 
Moreover, previous reports have revealed that higher concentrations of P407 are required in a 
formulation when used on its own; such concentrations were found to be irritant to the eye. In 
order to overcome this challenge, researchers adopted the approach of blending  P407 with 
other polymers like methyl cellulose, chitosan, and P188  in order to decrease the total 
concentration of P407 used, improve its gelling characteristics as well as mechanical 
properties of P407 and reduce its ocular irritation potential (Almeida, et al., 2014). 
Ketorolac tromethamine (KT) is a non-steroidal anti-inflammatory drug that has potent 
analgesic activity; it is used for treating post-operative eye inflammation and reducing 
conjunctivitis (Gupta et al., 2000; Sunil et al., 2013). There are other potent NSAIDs that are 
currently used for ophthalmic conditions e.g. nepafenac 0.1% w/v (Nevanac®) which is a 
prodrug that is rapidly converted into amfenac after passing through the cornea. Also, 
bromfenac 0.09% w/v (or 0.1% w/v when labelled as the salt form) (Xibrom® and 
Bromday®) is available as ophthalmic solution. A previous animal study demonstrated that 
bromfenac 0.09% w/v, pH 8.3 readily penetrates ocular tissues. Both drugs are used for the 
treatment of pain and inflammation associated with cataract surgery (Baklayan & Muñoz, 
2014; Kim et al., 2010). 
It has been reported that the ocular bioavailability was up to 4% for the KT ophthalmic 
solution (0.5% w/v) following topical ocular administration in the form of conventional eye 
drops in anesthetized rabbits. The drug concentrations in the aqueous humour were compared 
after topical application with those obtained after intracameral injection of an equivalent dose 
of 0.25 mg of ketorolac tromethamine per eye using 14C (Ling & Combas, 1987; Walters et 
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al., 2007).  Such factors have  prompted research for the development of a more safe and 
effective  KT formulations (Schoenwald, 1985; Sinha et al., 2009). Various in situ 
ophthalmic preparations have been formulated incorporating KT in order to sustain its 
release, thus improving its ocular bioavailability as well as reducing the frequency of 
administration. Nanjwade  et al. prepared pH-triggered in situ gel for sustained ophthalmic 
delivery of ketorolac tromethamine, using carbopol 934 and hydroxypropylmethylcellulose 
(Nanjwadea et al., 2009). Also, KT has been used in form of hydrogel for nasal delivery 
using poloxamer 407 and carrageenan (Li , et al., 2014) 
More recently, ofloxacin loaded Pluronic F127 and Pluronic F68 (20% w/v) in situ gelling 
formulation have been prepared and characterised. These deemed promising ocular 
formulation due to prolonged pre-corneal retention and good ocular tolerability using slug 
mucosal irritation assay and bovine corneal erosion study (Al Khateb et al., 2016 ).   
The present study focuses on investigating into different polymer combination of P407 and 
P188 for ocular delivery of the non-steroidal anti-inflammatory drug KT. Physicochemical 
characterisation of drug/polymer interactions were investigated with DSC and FT-IR studies. 
The gelling properties and rheological characteristics for these formulations were studied. 
The mucoadhesive characteristics, in vitro release as well as ex vivo corneal permeation of 
KT were investigated. Furthermore, the ocular irritation potential of the KT-loaded in situ gel 
formulations was determined using a combination of the HET-CAM and BCOP tests. Finally 
the MTT cytotoxicity assay was carried out using a corneal epithelial cell line in order to 
elucidate the toxicity of the developed KT-loaded in situ gel formulations. 
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2. Materials and methods 
2.1. Materials 
Ketorolac tromethamine (KT), poloxamer 407 (P407, culture tested), and poloxamer 188 (F-
168) were purchased from Sigma Aldrich chemical Co., Gillingham, UK. Whole fresh 
porcine eyes were purchased from C.D Jennings & Sons abattoir, Surrey, UK. All other 
chemicals and solvents were of analytical grade and used as received from the supplier. 
Fertilised white Leghorn eggs were purchased from Henry Stewart & Co. Ltd. Fakenham, 
Norfolk, UK. Bovine eyes were purchased from ABP Guildford Slyfield Industrial Estate, 
Guilford, UK. Primary Corneal Epithelial Cells; Normal, Human (ATCC® PCS-700-010™) 
were acquired from ATCC company, Manassas, VA, USA. 
 
2.2. Determination of drug – polymer interactions 
2.2.1. Differential scanning calorimetry (DSC) study 
DSC study was carried out on Mettler Toledo DSC 822e0, Switzerland. The drug, the 
polymers (P407 and P188) as well as their physical mixtures (PM) with KT was weighed 
separately in aluminium pans, covered with aluminium lids and hermitically sealed using a 
pan press (Thermal Science, USA). Once in the calorimeter, the temperature of the pan was 
gradually increased from 25
o
C to 300
o
C at a rate of 10
o
C/min. Nitrogen was purged at a flow 
rate of 45 mL/min. The data generated was consolidated using Mettler STARe software 
version 8.10. 
2.2.2. Fourier transform infrared spectroscopy (FT-IR)  
FT-IR spectrometer (Thermo Scientific Nicolet iS5, Thermo fisher, USA) was used to record 
the FT-IR spectra of KT, P407, and P188 and their PM. Sufficient amount (2 - 4 mg) of the 
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sample was placed to form a thin film covering the diamond window. The FT-IR spectra 
were recorded at a resolution of 2 cm
-1
 with an average of 120 scans. The data was acquired 
and analysed using Omnic software (Omnic version 8.2, USA).  
2.3. Preparation of in situ gel formulations 
Different amounts of P407 and P188 were dissolved in cold deionised water that has been 
equilibrated at 4 – 8oC before use to prepare various concentrations of P407: P188 (% w/v). 
The solutions were stirred for 2 h and within this period 5 mg/mL KT is added to the 
preparation and then kept in a refrigerator for at least 24 h to ensure complete dissolution. 
 
2.4. Determination of physical properties of in situ gels 
Before performing characterisation studies all preparations were subjected to visual 
examination for clarity, prior to and after gelation, then the gelation temperature and time 
were determined as follows.  
 
2.4.1. Determination of gelation time and temperature 
The gelation time was determined using an aluminium pan which was placed on a hot plate 
equilibrated at (35
o
C). A few drops of each test solution were instilled onto the pan using a 
Pasteur pipette. The pan was then tilted at 90
o
 to examine the gelation. The final gelation time 
is recorded when the free flowing solution transforms into a thick textured gel and ceases to 
flow (no change in meniscus) upon tilting by up to 90
o
. The gelation temperature or the sol-
gel transition temperature (Tsol-gel) was determined by the tube inversion method. Briefly, the 
test solution was placed in a test tube which was dipped in a water bath maintained at a 
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temperature of 40.0 ± 1
o
C for 5 min. The temperature at which the test solution was 
converted to gel ceases to flow with no change in meniscus upon tilting up to 90
o
, was 
recorded.  
2.5. Determination of rheological properties of in situ gel formulations 
The viscosity of different P407 and P188 based formulations were measured using a 
Brookfield viscometer (DV-II+Pro), Brookfield Engineering LABS. Inc. MiddleBoro, MA, 
USA. Spindle type 62 was used at different shear rates (10, 20, 50, and 100 rpm) at 4
o
C and 
matching spindle rate to get the working range of the torque. Measurements were carried out 
where 25 mL sample was placed in a glass tube and the rotation speed was kept constant for 
at least 60 s before a reading was taken to ensure consistency among different preparations 
which were done in triplicate and the mean values ± SD were calculated.  
2.6. Mucoadhesion of in situ gel formulations 
The mucoadhesion ability of the formulated in situ gel systems was determined using a TA-
XT plus texture analyser (Stable Micro Systems, UK) in a special adhesive mode. The in situ 
gel formulations PP3, PP7, PP11 and PP12 were selected based on their predetermined 
gelation time, Tsol-gel, and rheological properties. Mucin discs were prepared by compression 
of porcine stomach mucin Type II (250 mg) using a ring press (10 mm in diameter) at a 
compression force of 10 tonnes, that was applied for 30 s. The discs were attached 
horizontally to the lower end of a TPA probe using double sided adhesive tape. About 35 g of 
each sample was placed in 50 mL glass cylinder and brought to 35°C using a thermostatic 
water bath. Then, the mucin discs that were previously attached to the probe  was brought in 
contact with the surface of the gel sample using a downward force of 5 g  which was applied 
for 180 s to ensure adequate contact between the mucin disc and the gel surface. The probe 
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was then raised at a speed of 0.5 mm/s to a predetermined distance of 5 mm and the 
established force–distance curve was recorded for each formulation. The force required to 
detach the mucin disc from the gel was recorded and denoted as the adhesion force (mN); the 
area under the force–distance curve was estimated as the work of adhesion (mN.mm)  (Xu et 
al., 2014).  
2.7. In vitro release study  
An aliquot (1 mL) of the formulation equivalent to 5 mg/mL KT was transferred to a donor 
chamber in Franz-diffusion cell; it was then occluded with parafilm. The receptor chamber 
(12 mL volume) was filled with PBS pH 7.4 and stirred constantly using small magnetic bar. 
Donor and receptor chambers were separated by means of a dialysis (cellophane) membrane 
with a molecular weight cut-off of 12,000 - 14,000 Da. pre-soaked in the receptor medium 
overnight prior to the experiment. The temperature was set at 35oC ± 0.5ºC. Samples (1 mL 
each) were withdrawn at predetermined time points for up to 12 h, and replaced with an equal 
volume of the receptor medium. The experiments were carried out in triplicate and the 
samples containing KT were determined by an in-house developed  HPLC method (Fathalla 
et al., 2015). 
 
 Ex vivo permeation study  
Corneas used in the ex vivo experiments were obtained from freshly collected porcine eyes. 
The eyes were examined for any visual defects and were stored in normal saline solution. 
Porcine cornea (0.67 mm) mimic human cornea (0.52 mm) anatomically although the former 
is slightly thicker than the latter (Faber et al., 2008; Worakul & Robinson, 1997). They were 
directly transported to the laboratory and used within few hours of enucleation. Franz 
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diffusion cell was used and the tissue was placed between the donor and the receptor 
compartments with the endothelial side facing the receptor compartment; temperature was 
maintained at 35
o
C and for each formulation, three corneas were used (n = 3). Then the same 
steps carried out in the in vitro release study were followed in this study. The amount of KT 
that permeated across porcine corneas was quantified by HPLC method. 
2.7.1. Ex vivo data analysis 
The apparent permeability coefficient (Papp, cm/s) was calculated according to the following 
equation 1 (Abdelkader, et al., 2011). 
                      
 ACot
Q
Papp
3600

                         Equation 1 
Where ∆Q/∆t is the permeability rate constant of KT across the excised porcine corneas. It 
was calculated from the gradient of the plot of the amount of KT permeated (Q) versus time 
(t); Co is the initial drug concentration (µg/mL), A is the corneal surface area (cm
2
) in contact 
with the formulation from the epithelial side and the release media from the endothelial side 
and 3600 is a factor used for the conversion of hours to seconds (s). The lag time (tL) was 
determined by extrapolating the linear plot to the x-axis. 
2.8. The Hen’s egg test on chorioallantoic membrane (HET-CAM)  
 
Freshly collected fertilised hen’s eggs (White Leghorn) were incubated at 37.5oC ± 0.5oC and 
66 ± 5% relative humidity (RH) for 3 days according to the HET-CAM procedure previously 
described by (Luepke, 1985). The eggs were kept horizontally in their trays and rotated 
gently every day to make sure that the embryo was positioned properly. After 72 h of 
incubation, the egg shells were opened by cracking the underside of the egg, then the eggs 
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were poured into a Petri dish, according to the modified HET-CAM method (Abdelkader et 
al., 2012; Alany et al., 2006; Rupenthala, et al., 2011). Once in the growing dish, the egg was 
examined for the viability of the embryo (intact CAM and yolk). Only viable embryos with 
an intact CAM and yolk sac were further incubated at previously mentioned conditions. 
On day ten, 200 µL of each test formulation was placed on the membrane. For each test 
substance three eggs were used. NaOH (0.5 M) was used as a positive control for a strong 
irritant effect, propylene glycol as a slight irritant, and normal saline as a negative control 
(Alany, et al., 2006). The blood vessels were examined for irritant effects like hyperaemia, 
haemorrhage and clotting after application for different time intervals (0.5 min, 2 min and 5 
min). The sum of the time-dependent numerical scores for all three irritant responses gave a 
single numerical value. This value interpreted the irritation potential of the test substance. 
The mean score value of the test allowed the assessment by a classification scheme analogous 
to the well-known Draize test (Luepke, 1985). A cumulative score of < or = 0.9 was 
considered as non-irritant; 1 < cumulative score < 4.9 was slight irritant; 5 < cumulative score 
< 8.9 was moderately irritant and 9 < cumulative score < 21 was severe irritant (Abdelkader 
et al., 2014). 
2.9. Bovine corneal opacity and permeability (BCOP) test  
Bovine eyes were obtained from a local slaughterhouse (Guilford Meat Processors, UK). The 
eyes were freshly collected and transported to the laboratory in cold saline and used on the 
same day. The eyes were examined for epithelium detachment, corneal opacity and corneal 
vascularisation. Eyes with corneal damage were discarded. Three different controls were used 
for validation purposes; 0.5 M NaOH was used as a strong irritant control (positive control),  
propylene glycol as a slight irritant, and normal saline as a negative control. The same 
components and formulations described in the HET-CAM test were investigated. Small 
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plastic cups were used to hold the eyes (cornea upwards), which were then placed in a humid 
atmosphere of a closed water bath at 37
o
C ± 0.5
o
C for 10 min (Weterings & Vanerp, 1987). A 
silicon O-ring (thickness 1.78 mm, an internal diameter 7.6 mm) was carefully placed on the 
central part of the cornea, to identify and localise the application site and ensure easy and 
reproducible test material application. One drop of saline was instilled inside the O-ring and 
the eyes were equilibrated in the closed water bath for 5 min. The test substance was applied 
to the cornea inside the ring at a volume of 0.1 mL test substance. After 30s, the eyes were 
rinsed with saline (approximately 10 mL), followed by further incubation in the closed water 
bath for an additional 10 min. Then, the extent of corneal injury was assessed by evaluating 
the opacity visually, followed by application of sodium fluorescein solution (2% w/v, pH 7.4) 
to examine the integrity of the corneal epithelium. The fluorescence was visualised using an 
examination lamp with a cobalt blue filter (Leica, GmbH, Germany). The observations were 
graded according to individual numerical scores for opacity, epithelial integrity (degree of 
staining) and epithelial detachment (Weterings & Vanerp, 1987). The scoring system of 
bovine cornea is based on assessing the disruption that a test substance can make to the 
epithelium barrier and consequently, corneal opacity and permeability induced. Corneal 
opacity which is determined by measuring the amount of light transmitted through the cornea, 
and corneal permeability is determined by measuring the amount of fluorescein dye that 
penetrates to the corneal stroma (Verstraelen  et al., 2013). The sum score was calculated and 
the mean scores for each of the 3 exposed eyes were used to interpret the corneal irritation 
potential of the tested formulations. 
2.10. MTT reduction cytotoxicity test 
The MTT cytotoxicity test was conducted according to Mosmann's procedure (Mosmann, 
1983) to assess mitochondrial function and cell viability of the corneal epithelial cells. 
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Primary human corneal epithelial cells (ATCC pcs-700-010) were prepared and seeded out at 
approximately 2x10
4
 cells/well into 96 well plates (Nunc) in Corneal Epithelial Cell Basal 
Medium containing (final concentration) the following supplements (LGC standards); apo-
transferrin (5 mg/mL), epinephrine (1.0 mM), Extract P (0.4%), hydrocortisone 
hemisuccinate (100 ng/mL), L-glutamine (6 mM), rh insulin (5mg/mL) and CE Growth 
Factor (1 mL, proprietary formulation).  
Cells were allowed to establish for 48 hours prior to treatment in the 96-well culture plate. 
Media were subsequently removed and fresh media containing treatments (4 wells used per 
condition) added. The treatments were in situ gel formulations both plain and loaded with 5 
mg/mL KT includes (PP7 and PP11) in addition to KT solution (5 mg/mL). These 
formulations were prepared in culture media and all the solutions were prepared under aseptic 
conditions. The untreated media was used as a negative control; meanwhile hydrogen 
peroxide (H2O2) (100 mg/mL) and benzalkonium chloride (BKC) at a concentration of 0.01% 
w/v were used as positive controls. After 4 h and 24 h of treatment, the media was aspirated 
carefully and the cells washed twice with 37
o
C sterile PBS. Cells were then incubated with 
200µl per well of 0.5 mg/mL 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) solution in 37
o
C Corneal Epithelial Cell Basal Medium (LGC standards) with no 
additions for 4 h at 37
o
C. After incubation, the MTT solution was carefully removed and the 
wells washed twice with sterile PBS. Finally, 200 µL of dimethyl sulfoxide (DMSO) was 
added to each well to lyse the cells. The cells were then gently agitated to mix the lysate and 
analysed on a TECAN Infinite M200 pro plate reader at a wavelength of 540 nm. 
Experiments were performed in triplicate and mean values were calculated. Results were 
expressed as a percentage of control cultures. 
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2.11. Statistical Analysis 
All experiments were performed on three independent preparations and a mean value was 
determined ± SD. Statistical analysis was performed using Graphpad Prism 6 (2014) 
software. A one-way analysis of variance (ANOVA) or a non-parametric Kruskal-Wallis test 
was performed on the data where appropriate. Dunnett’s post hoc test was performed and a P 
value of < 0.05 and < 0.001 was considered to be statistically significant. 
 
3. Results and discussion 
Previous reports suggest that P407 and P188 solutions individually cannot undergo sol-to-gel 
transition at temperatures appropriate for ocular application (Abdelkader & Alany, 2012; 
Abdelkader & Mansour, 2015). For example, preformulation studies showed that P407, at a 
concentration of 10% and 30% w/w, has gelling temperatures which are higher than 40
o
C and 
lower than 25
o
C, respectively. However, by tailoring poloxamer mixtures of specific 
concentrations, it is possible to modulate the gelation temperature and to obtain a sol-gel 
transition temperature (Tsol-gel) suitable for ocular application, i.e. near to corneal temperature 
(35
o
C) (Mayol et al., 2008).  
3.1 Evaluation of drug -polymer interactions 
3.1.1. Differential scanning calorimetry (DSC) study 
 Figure 1A shows the thermal traces of KT, P407 and their PM (1:1 w/w). The thermal 
behaviour recorded for KT comprised two endothermic peaks at 168.9
o
C, and 167.5
o
C. These 
peaks related to the melting of KT. This is typical to the thermal melting behaviour of 
tromethamine salt (KT salt) (Abdelkader et al., 2007) 
On the  other hand, P407 showed endothermic peak at 50°C due to its melting point and this 
result complies  with the data  reported elsewhere (Garg et al., 2013). The PM of KT and 
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P407 showed two endothermic peaks at 158ºC and 51ºC, corresponding to the melting points 
of both the polymer (up) and that of drug which showed slight shift to a lower single peak 
(down) respectively, which suggested that there may be a weak interaction between drug and 
P407. This could be due to possible electrostatic interaction between the drug and the 
polymer. 
Figure 1B indicates that there was no difference in the DSC traces of P407-KT and P188-KT. 
The DSC traces for KT, P188 and their PM showed the same thermal behavior as that 
obtained with P407-KT traces. 
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Figure 1A: DSC traces for ketorolac tromethamine (KT), poloxamer 407 (P407), and 
their physical mixture (PM). 
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Figure 1B: DSC traces for ketorolac tromethamine (KT), poloxamer 188 (P188), and 
their physical mixture (PM). 
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3.1.2. Fourier transform infrared spectroscopy (FT-IR) study 
Figure 2 shows FT-IR spectra characteristic of KT (figure 2A), P407 (figure 2B), and their 
physical mixture (KT-P407 PM) (figure 2C) as well P188 (figure 2D) and its physical 
mixture with the drug (KT-P188 PM) (figure 2E) o er the range  000- 00 cm   1. For KT 
spectrum, major peaks (3,343 cm
-1     stretch   1 1   cm   1       stretch (diaryl  etone)  
and 1 11 cm   1 due to C-C aromatic stretching are seen. Also the peak observed at 728 cm-1 
which is related to aromatic C–H bending vibration; aliphatic C–H bending vibration is 
observed at 1375 cm
−1
. The peak at 1556 cm
−1 
is due to carbonyl C=O stretching vibrations 
(Ajit P. et al., 2006). 
Figure 2B, shows P407 characteristic peaks at around 3000 cm
-1
 and around 1100 cm
-1
. The  
principal absorption bands (stretching) at 3463 cm
-1
 correspond to the following functional 
groups; (O-H), 2874 cm
-1
 (CH), 1096.9 cm
-1
 (C-O). Our spectra for P407 was comparable 
with the previously recorded FT-IR spectra of P407 (Newa et al., 2008). There was no 
significant change in the absorption spectra for the drug when incorporated into PM (figure 
2C). The incorporation of drug into poloxamer did not modify the position of the major peaks 
for KT (3,343 cm
-1     stretch   11   cm   1       stretch (diaryl  etone)  and 1 11 cm   1 due 
to C-C aromatic stretching; 1556cm
−1 
due to carbonyl C=O stretching vibrations showed a 
minor shift to 1    cm  1. On the other hand, the FT-IR spectrum for P188 (figure 2D) shows 
that P188 has a characteristic spectrum with peaks at around 3000 and 1100 cm
−1
. P188 
exhibited characteristic peaks at 3449 cm
-1
, 2876 cm
-1
, and 1096.8 cm
-1
 due to stretching of 
O-H, C-H, and C-O groups respectively. The FT-IR spectrum for the physical mixture of KT 
and P188 (figure 2E) did not show any shifts in the peaks of both the drug and the polymer 
but the intensity of the peak slightly decreased which may be due to the dilution of the drug 
with the polymer compared with KT alone. Thus, it can be concluded that based on FT-IR 
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spectra there is no interaction between the drug and polymer in the PM.
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Figure 2: FT-IR spectra for ketorolac tromethamine (KT) (A), poloxamer 407 (P407) 
(B), and their physical mixture (KT-P407 PM) (C), poloxamer 188 (P188) (D), and their 
physical mixture (KT-P188 PM) (E). 
 
3.2. Characterisation of in situ gel formulations  
Different combinations of P407 and P188 were trialled to prepare the in situ gel formulations. 
Visual observation showed that poloxamer-containing in situ gel formulations were clear, 
colourless and transparent. Clarity is a highly desirable characteristic in ophthalmic 
formulations as non-transparent formulations may blur the vision and are not acceptable by 
the patient (Thakor et al., 2012).  The physicochemical characteristics of KT loaded in situ 
gel formulations were found to be affected by the polymer compositions. For example, 
increment of P407 content decreased Tsol-gel of the formulation while increase in P188 
concentration tended to increase Tsol-gel, as presented in Table 1. These results are in a good 
E 
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agreement with those obtained by Asasutjarit et al. who investigated the effectiveness of 
diclofenac sodium loaded in situ gel formulations (Asasutjarit et al., 2011). All samples 
prepared at various concentrations presented in Table 1 were clear and transparent in both 
liquid and gel state. 
 The pH of P407/P188 in situ gel formulations were measured using a pre-calibrated pH-
meter. All the formulations were found to have neutral pH, ranging between 6.43 ± 0.1 to 
7.06 ± 0.01 (Table 1).  
 
The gelation time measured for all prepared formulations is presented in Table 1. It is clear 
from the data shown that at constant P188 concentration, the gelation time of different 
formulations decreased as the concentration of P407 increased. For instance, there was a 
significant difference (P < 0.001) between formulations PP10 and PP11 where their gelation 
time was 53.0 ± 16.9 s and 16.3 ± 5.03 s respectively. Also, upon comparing PP5 and PP6 
formulations, there was a significant (P < 0.001) decrease in the gelation time from 256.0 ± 
29.50 s to 43.3 ± 20.80 s. On the other hand, comparing formulations PP11 and PP12, it was 
noted that there was no significant difference (P > 0.05) in the time required for their gelation 
and the same is also true for formulations PP2 and PP3. However, some samples did not 
experience gelation at all despite being exposed to physiological temperature and higher, e.g. 
PP1 formulation did not undergo gelation even after 5 min and its Tsol-gel was over 40
o
C. This 
was ascribed to the lower concentrations of both polymers used which would make the 
formulation relatively more hydrophilic even at a higher temperature. Hence, samples PP1 
and PP9 were excluded from further studies.  
On the other hand, it is obvious from the data shown in Table 1 that an increase in P188 
concentration leads to increase in Tsol-gel of the resultant gel. According to Dumortieret al. 
Tsol-gel transition temperature of any in situ gel formulation increases when P407 
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concentration decreases (Dumortier  et al., 2006). In our preformulation study (data not 
shown), when formulations were prepared using P407 alone, the gelation temperature 
decreased with increasing P407 concentration.  Increasing the concentrations of P188 in the 
P407 polymer based in situ gels an increase in Tsol-gel of these formulations was noted, which 
was within the physiological range, compared to the gels containing P407 alone. For 
example, in Table 1 the comparison of the sol-gel transition temperatures of PP4, PP8 and 
PP12 suggested that the formulation that contained more P188 exhibited sol-gel transition at 
a higher temperature. This may be due to the fact that the more hydrophilic P188 possesses a 
lower ratio of PPO units/PEO units per mole (0.19), compared to P407 (0.32), and could 
disrupt the hydration layers surrounding the hydrophobic part of P407 molecules. It caused 
higher order of water molecules around the hydrophobic PPO units. When gelation occurred, 
these ordered water molecules had to be squeezed out into the bulk solution. Therefore, the 
increase in the temperature was required for the system to promote the hydrophobic 
interactions between the formed micelles  (Asasutjarit, et al., 2011; Vadnere et al., 1984). In 
another study, it was noted that P188 concentration could not be increased  over 15% w/v as 
this would render the formulation poorly flowable at room temperature which is not a 
desirable property for an in situ gel that is intended for topical ocular application; such a 
formulation should exhibit solution characteristics (easy to instil) at room temperature  thus 
enabling easier ocular administration (Asasutjarit, et al., 2011).  Also, Wei et al. reported the 
effect of high P188 concentration on sol-gel transition temperature of the formulations  as he 
stated that an optimized formulation containing 21% F127 and 10% F68 increased the phase 
transition temperature by 9°C (Wei, et al., 2002).  
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3.3. Determination of rheological properties and viscosity of in situ gel formulations 
  As shown in Table 1, all gel formulations exhibited a characteristic pseudoplastic (shear 
thinning) flow behaviour at room temperature. The viscosity increased significantly             
(P < 0.001) with increasing concentration of P188 as well as P407 for all tested formulations. 
This may be explained by the fact that any incremental increase in the shear rate, results in 
the alignment of the  polymer chains parallel to each other along their axes in the direction of 
a flow, thus reducing the internal resistance of the material and lowering  viscosity (Abou El-
elaa & El- khatib, 2014). The viscosity of the formulations decreases with increasing shear 
rate in the presence of hydrophilic additives (Table 1). For example, the viscosity of PP11 in 
situ gel formulation at 10 rpm was 574 ± 17.99 mPas, however, further  increase in the shear 
force to 100 rpm resulted  in a significant decrease (P < 0.001) in the viscosity of the 
formulation (451.1 ± 16.34 mPas, Table 1). Also, the formulations acquire more fluidity, 
which improves their flow properties. These results are in a good agreement with those 
obtained by Ricci et al. who reported that P407 gels were pseudoplastic ; therefore, when 
shear deformed, their viscosity decreases (Riccia et al., 2002). 
These results are in a good agreement with those obtained by El-Kamel et al. who explored 
the properties of different pluronic F-127 formulations comprising methylcellulose, 
hydroxypropylmethy cellulose, and sodium carboxymethyl cellulose (El-Kamel, 2002). Also, 
the pseudoplastic behaviour of F127 formulations loaded with ciprofloxacin hydrochloride 
was observed previously by (Mansour et al., 2008). 
 
 
 
 
  
26 
 
 
Table 1: Properties of different combination of poloxamer 407 (P407) and poloxamer 188 (P188) in situ gel systems and the effect of 
shear force on the rheological properties of P407/ P188 based in situ gel formulations. Results are expressed as mean values ± SD, (n=3).  
* = No gelation observed even after several minutes.  
 
 
 
Formulatio
n 
code 
 
 
P407 
(%w/v) 
 
 
P188 
(%w/v) 
 
 
pH 
 
Gelation 
temperature 
(
o
C ) 
 
 
Gelation 
time 
(s) 
 
Viscosity (mPas) 
 
10rpm 
 
20rpm 
 
50rpm 
 
100rpm 
PP1 15 5 7.06±0.01 Over 40 * - - - - 
PP2 20 5 6.81±0.02 29.5±0.5 30.7±4.51 460.5±2.1 420.9±2.8 338.0±4.2 265.0±3.2 
PP3 23 5 6.87±0.10 32.5±0.5 17.7±1.52 456.8±19.4 448.0±4.4 407.6±3.6 379.0±11.3 
PP4 25 5 6.85±0.003 30.0±0.5 13.5±3.00 507.8±10.1 490.1±8.1 46.5±2.8 421.4±5.5 
PP5 15 10 6.71±0.01 Over 40 256.0±29.50 335.3±18.8 325.6±7.9 308.0±8.5 301.5±9.2 
PP6 20 10 6.43±0.10 34.0±1.0 43.3± 20.80 403.9±2.8 397.9±8.7 374.5±19.1 346.5±13.4 
PP7 23 10 6.88±0.02 33.5±0.5 21.0±2.50 573.1±7.9 560.4±10.5 520.0±1.4 490.5±4.1 
PP8 25 10 6.95±0.001 31.5±0.5 20.0±1.25 627.7±3.4 609.0±4.8 588.1±11.5 552.0±6.5 
PP9 15 15 6.89±0.03 Over 40 105.0±13.23 - - - - 
PP10 20 15 6.93±0.01 28.5±1.5 53.0±16.09 438.0±21.8 431.8±1.8 3279.0±5.1 351.9±8.0 
PP11 23 15 6.99±0.02 33.2±1.0 16.0±5.03 574.0±17.9 561.8±11.0 501.7±14.0 451.1±16.3 
PP12 25 15 7.00±0.01 32.5±0.5 12.5±1.60 733.0±15.2 711.0±9.5 681.9±7.1 655.0±4.3 
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3.4. Evaluation of mucoadhesive properties of in situ gel formulations  
 
The data presented in Figure 3 show that increasing either P407 or P188 concentration leads 
to a significant increase (P < 0.001) in the detachment force for all tested formulations.  For 
example, the detachment force of PP3 and PP12 was found to be 74.05 ± 6.72 mN and 104.1 
± 6.11mN, respectively. On the other hand, the work of adhesion of the tested formulation 
increased with increasing concentration of P188. However, upon increasing the concentration 
of P407 when comparing formulations P11 and PP12, the work of adhesion decreased 
significantly (P < 0.001) from 377.9 ± 7.79 mN.mm to 272.3 ± 6.11 mN.mm. This may be 
attributed to the mucoadhesive characteristics of these polymers upon gelation as well as the 
relatively high molecular weight of the two polymers (P407 and P188) as both polymers have 
an average molecular weight (MW) of around 8400 Da. As with the increase in the molecular 
weight of the polymer chain there is an increase in the mucoadhesiveness of a polymer 
(Mythri .G et al., 2011). 
 It has been shown previously that the stronger the mucoadhesive force, the greater is the 
amount of formulation that is retained on the ocular surface (Baloglu et al., 2011). However, 
if the mucoadhesive force is excessive, the gel might damage the mucous membrane present 
on the ocular surface (Abdelkader & Mansour, 2015).  
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Figure 3: Detachment force and work of adhesion of P407-P188 in situ gel formulations. 
Results are expressed as mean values ± SD, (n=3). 
 
3.5. In vitro release study 
Figure 4 shows the release profile of different in situ gel formulations. P188 and P407 
retarded the dissolution of the drug in a concentration-dependent manner as the release rate of 
KT decreased with increasing P407/P188 ratio. PP3 formulation gave the highest drug release 
rate among all tested ratios since nearly 90% of the total amount of KT released within 7 h, 
but still exhibited a sustained drug release compared with KT solution. Also, a significant 
difference (P < 0.001) was noted in the release profiles of all tested in situ gel formulations 
when compared with KT solution. Furthermore, increasing P407 concentration while keeping 
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P188 concentration constant has resulted in 50% drug released within a period of 12 h 
(Figure 4). 
This effect on the release may be due to the presence of P188 in high concentration which 
increases the polymer chain entanglement as well as the viscosity of P407 solutions. Both 
polymers together yielded thick gel at 35
o
C that hardly released KT. Also, as shown in Table 
1, the addition of P188 into different concentrations of P407 (20, 23 and 25% w/v) raised the 
sol-gel transition temperature of in situ gel formulations. 
It can be concluded from the release data that P407 molecules form tight gel structures via 
hydrogen bonding in the aqueous solution. Moreover, as KT is water-soluble it interacts with 
poloxamer thus resulting in a delay in the drug release pattern. Thus, the rate of release of KT 
is decreased due to the delay in both gel dissolution and drug diffusion. 
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Figure 4: Release profile of KT from different P188 and P407 (% w/v) in situ gel 
formulations in PBS (pH 7.4). Results are expressed as mean values ± SD, (n = 3). 
 
 
 
3.6. Ex vivo permeation study 
Two in situ gel samples have been selected for this study (PP7 and PP11) depending on their 
mucoadhesive characteristics as well as their in vitro release profile. Table 2 shows a 
comparison of the ex vivo data of these two formulations with that of KT solution. The steady 
state flux for KT solution was significantly (P < 0.05) higher than PP7 and PP11 as it was 
2.37 and 4.28 folds faster than that of PP7 and PP11 formulation, respectively. While the 
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value of Papp for these in situ gel samples were lower by 2.4 and 4.3 folds for PP7and PP11 
respectively compared with the Papp value for KT solution, Table 2. KT took longer time to 
partition through gel matrix and furthermore time to diffuse through poloxamer-based matrix 
compared to free KT using the static Franz diffusion cells model. This can be explained on the 
ground that while the drug solution showed better permeation rates compared with the gel systems on 
the static receptor compartment of the Franz diffusion model used in this study, there is an extensive 
body of research to suggest that this pattern can be reversed in vivo. Similar results were reported 
with methyl cellulose and carrageenan-based in situ gels using excised bovine sclera 
(Thrimawithanaa, et al., 2011) and other vesicular delivery systems, such as liposomes, 
niosomes and solid lipid nanoparticles (SLNs), using excised rabbit, excised bovine and 
bioengineered human corneal sample (Abdelkader, et al., 2011; Attama et al., 2009; Law et 
al., 2000).  
On the other hand, the tL calculated  for the selected in situ gel samples used in this study are 
shown in Table 2. It was found that PP7 formulation gave the longer tL compared with PP11 
and also longer time compared with KT solution. As the tL values for PP7, and PP11 was 
0.526 ± 0.66 h, and 0.268 ± 0.38 h. respectively. This may be due to the fact that the in situ 
gel at 35
o
C (experiment temperature) form a viscous gel that would delay KT permeation 
through the cornea compared with solution. In addition to the mucoadhesive properties of the 
in situ gel is likely to retain the drug on the corneal surface for a prolonged time, furthermore, 
these formulations spread and adhered to the hydrophobic surface of the cornea better than 
the aqueous drug solution. 
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Figure 5: Transcorneal permeation profiles of ketorolac tromethamine (KT) from KT 
solution PP7 and PP11 in situ gel formulations using excised porcine corneas. Results 
are expressed as mean values ± SD, (n = 3). 
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Table 2:  Steady-State Flux, Apparent Permeability Coefficient (Papp), and Lag Time 
(tL) of KT after ex vivo corneal permeation study. Results are expressed as mean values 
± SD, (n = 3). 
 
 
 
 
 
 
 
 
 
 
 
 
3.7. HET-CAM (Hen’s Egg Test on Chorioallantoic Membrane)    
This test has been used for evaluation of conjunctival response to test material, and it has 
been recently reported as a well-accepted in vitro conjunctival membrane model(Abdelkader 
et al., 2015). A modified method of the conventional one was reported in the literature, where 
the embryo was grown in a Petri dish from day 3 onwards to allow ready access to the entire 
CAM surface for better visibility and convenience (Auerbach et al., 1974; Dohle et al., 2009).  
The selected PP7 and PP11 in situ gel formulation demonstrated no irritation potential and no 
signs of inflammation on the CAM during the test period. Furthermore, the gel formulation 
loaded with KT (0.5%w/v) imparted a protective effect through the formation of a diffusional 
barrier against the caustic effect of NAOH on the CAM, Figure 6. 
 
Formulation 
Code 
 
Steady-State 
Flux (µg/h) 
 
Papp × 10
-6
 
(cm/sec) 
 
tL (h) 
 
KT- solution 
 
117.65±0.96 
 
5.31±0.13 
 
0.198±0.34 
 
PP7 
 
49.58±1.23 
 
2.24± 0.22 
 
0.526±0.66 
 
PP11 
 
27.46±0.67 
 
1.24±0.73 
 
0.268±0.38 
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On a time dependent numerical score for three irritant responses, a single cumulative value is 
estimated to interpret the irritation potential of different formulations. Figure (7A) shows the 
cumulative HET-CAM scores for the controls; KT solution (5 mg/mL) in PBS, the test 
polymers used in the formulation process and the KT loaded in situ gel formulation. 
The cumulative scores for KT solution, P407 and P188 were 0.43 ± 0.10, 0.53 ± 0.15 and 
0.48 ± 0.11 respectively (Figure 7A). This is an indication that the drug and the polymers 
used in the formulation process were not irritant to the CAM. Also, Chena et al. confirmed 
that P407 is a non-irritant substance in their study involving liquid crystalline nanoparticles. 
These formulations exhibited excellent ocular tolerance according the ocular irritation testing 
method used (Chena et al., 2012). Also,  Rooks et al. reported that KT solution when instilled 
into the eyes of rat and rabbit models of ocular inflammation, inhibited the inflammatory 
response and were seen to be a non-irritant (Rooks W.H. 2nd et al., 1985). 
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Figure 6: Images showing the protective effect of KT loaded in situ gel (PP11) 
formulation on 10 day old CAM  after treatment with NaOH at different time intervals 
(A) 0.5 min, (B) 2 min, and (C) 5 min. 
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Figure 7: Cumulative HET-CAM scores (A) and cumulative BCOP scores (B) for the 
controls, KT solution, used polymers, and formulations PP7 and PP11. Results are 
expressed as mean values ± SD, (n = 3). 
 
3.8. The BCOP (Bovine corneal opacity and permeability) assay  
Figure 8 represents the degree of corneal opacity and fluorescein permeability used to score 
the test substances. These substances included mild irritant (propylene glycol) and strong 
irritant (NaOH 0.5 M). 
Figure 8 shows photographs for normal cornea before and after staining as well as the effect 
of different types of controls used in this experiment. Also, data presented in Figure 7B 
indicates the cumulative scores for different in situ gel formulations, KT solution (5 mg/mL) 
in PBS along with polymers to make the in situ gelling formulation. It is clear from the data 
that KT solution did not show any signs of irritation and the same is also true for the in situ 
gel formulations as the cumulative score was not more that 0.5. Similar results have been 
reported by Kadam et al. where the in situ gel formulations for ocular delivery of ketorolac 
tromthamine conatining combination with hydroxypropylmethyl cellulose and P407 were 
stable and  non-irritant (Kadam et al., 2010).  
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On the other hand, the cumulative scores for P407, and P188 and KT solution  alone indicate 
a mild irritation potential  (Figure 7B). These results for the BCOP test are consistant with 
those obtained using the HET-CAM test, as both the experiments revealed that the tested 
formulations were non-irritant to the models employed in the study.  
 
 
Figure 8: Degree of corneal opacity (upper) and fluorescein permeability (lower) used to 
score the test substances [mild irritant (propylene glycol) and strong irritant (NaOH 0.5 
M) models. 
 
3.9. MTT cytotoxicity assay 
Selected in situ gel formulations (PP7 and PP11) both drug free and loaded with KT 
(5mg/mL) were used in this experiment. As stated before the MTT assay is a quantitative 
colorimetric assay that measures the activity of the mitochondrial cells as an index of their 
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viability and proliferation. This test only detects living cells, and the signal generated is 
directly proportional to the number of live cells (Angius  & Floris 2015; Yang et al., 2015). 
Figure 9 shows estimated cell viability after a 4 h and 24 h exposure to different treatments.  
The positive control (BKC 0.01%) has been shown to be cytotoxic at the duration tested in 
this study. Whilst there were a noticeable decrease in cell viability after exposure to the 
different in situ gel formulations and KT solution, these were statistically significant 
compared to the negative control (P < 0.001). But the difference between % cell viability 
were not remarkable (P > 0.05) when comparing KT solution with plain formulation but the 
difference was significant (P < 0.05) when comparing KT loaded formulations with KT 
solution. Meanwhile there was significant (P < 0.01) difference between positive controls and 
KT solution and tested formulations.  It is worth nothing that BKC (which for durations 
comparable to this study is cytotoxic) is used routinely as a preservative in commercial 
ophthalmic eye drops at the tested  concentration of 0.01% w/v ; the duration of exposure of 
the eye when BKS is applied in eye drops is considerably shorter. These findings indicate that 
KT loaded in situ gel formulations exhibit acceptable percent cell viability according to the 
regulatory requirements for ophthalmic pharmaceuticals which should be tolerable to the 
ocular surface compared with control samples as shown in Figure 9. Thus, the tested 
formulations are considered suitable for ocular application taking into consideration the tear 
turnover and the time these formulations are likely to remain in the eye. 
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Figure 9:  MTT assay results on primary corneal epithelial cells after 4h and 24h 
treatment with plain and loaded in situ gel formulations. Results are expressed as mean 
values ± SD, (n=3). * Significant difference; ** non- significant difference.  
 
 Conclusion 
This study demonstrated the favourable rheological and gelling properties of the investigated 
poloxamer formulations. The KT-loaded formulations exhibited desirable rheological 
properties as well as mucoadhesive characteristics. Furthermore, in vitro and ex vivo 
permeation study revealed that the prepared in situ gels sustained drug release pattern when 
compared with KT solution. While the drug solution showed better permeation rates compared with 
the prepared PP7 and PP11 systems on the static receptor compartment of the Franz diffusion model 
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used in this study, there is an ample body of research to suggest that this pattern can be reversed in 
vivo. In an in vivo setting there will be many factors affecting the drug permeation, such as 
tear turnover and blinking. This is a static model and any delay in the flux rate can be 
compensated by prolonging the precorneal residence time and this is clear from the results 
obtained from mucoadhesion and viscosity tests. Additionally, the gels did not show any 
signs of conjunctival or corneal irritation as revealed by the HET-CAM or BCOP tests 
respectively. MTT cytotoxicity assay data demonstrated that the selected in situ gel 
formulations showed reasonable and acceptable percent of cell viability when compared with 
control samples.    
Thus, due to the strong concentration dependence of the sol–gel transition temperature 
combined with acceptable corneal epithelial cell viability, it can be concluded that KT loaded 
thermoresponsive in situ gel formulations (PP7 and PP11) with concentration of P407:P188 
(23:10 w/v%) and (23:15 w/v%), respectively appeared to be a promising ocular delivery 
system for KT delivered across the cornea. 
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Figure 1: In this study, the thermoresponsive behaviour of poloxamers was employed as a 
trigger for the formation of in situ gel systems incorporating ketorolac tromethamine (KT) (A).  
The protective effect of KT loaded in situ gel preparation on 10 day old chorioallantoic 
membrane (CAM) has been investigated after treating the CAM with a strong irritant, NaOH 
(B). The BCOP test revealed the corneal opacity and permeability of the prepared in situ gel 
system (C). The MTT cytotoxicity assay demonstrated that the cell viability when treated with 
the selected in situ gel preparations was at an acceptable level compared to the control 
samples (D). 
 
